Chongqing Pharscin Pharmaceutical Co., Ltd.

SZSE:002907 주식 보고서

시가총액: CN¥5.8b

Chongqing Pharscin Pharmaceutical 대차 대조표 상태

재무 상태 기준 확인 6/6

Chongqing Pharscin Pharmaceutical has a total shareholder equity of CN¥1.7B and total debt of CN¥105.2K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CN¥1.9B and CN¥254.4M respectively. Chongqing Pharscin Pharmaceutical's EBIT is CN¥66.1M making its interest coverage ratio -27. It has cash and short-term investments of CN¥471.9M.

주요 정보

0.006%

부채 비율

CN¥105.16k

부채

이자 보상 비율-27x
현금CN¥471.87m
주식CN¥1.66b
총 부채CN¥254.44m
총 자산CN¥1.91b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) Popularity With Investors Is Under Threat From Overpricing

Oct 03
Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) Popularity With Investors Is Under Threat From Overpricing

Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) 30% Price Boost Is Out Of Tune With Revenues

Mar 06
Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) 30% Price Boost Is Out Of Tune With Revenues

재무 상태 분석

단기부채: 002907's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥207.5M).

장기 부채: 002907's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥46.9M).


부채 대 자본 내역 및 분석

부채 수준: 002907 has more cash than its total debt.

부채 감소: 002907's debt to equity ratio has reduced from 20.9% to 0.01% over the past 5 years.

부채 범위: 002907's debt is well covered by operating cash flow (138775.9%).

이자 보장: 002907 earns more interest than it pays, so coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기